Prostate Cancer: Where Are We in 2018?

Estimated time to complete session: 60 mins.

Learning Objectives

Upon completion of this session, you should be able to:

1. Implement patient education tools on PSA screening benefits and harms to enable patients to make informed choices.
2. Using shared decision-making, assist patients in the informed decision for or against PSA screening.
3. Explain treatment options for patients diagnosed with low-risk prostate cancer, including benefits and harms associated with conservative and invasive management strategies.

Additional Information

Technical Requirements: 

View technical requirements (opens in a new window).

CME Credit Information: 

View CME credit information (opens in a new window).

Disclosures: 

View disclosures and disclaimers (opens in a new window).

Course summary
Available credit: 
  • 1.00 AAFP prescribed
Course opens: 
03/25/2014
Course expires: 
09/26/2021

Joel J. Heidelbaugh, MD, FAAFP, FACG, Clinical Professor, Departments of Family Medicine and Urology, University of Michigan Medical School, Ann Arbor, Michigan

Available Credit

  • 1.00 AAFP prescribed

Accreditation Period

Course opens: 
03/25/2014
Course expires: 
09/26/2021
Please login or register to take this course.